The genetics of Parkinson's disease: review of current and emerging candidates

被引:5
|
作者
Ran, Caroline [1 ]
Belin, Andrea Carmine [1 ]
机构
[1] Karolinska Inst, Dept Neurosci, Retzius Vag 8,B2 4, S-17177 Stockholm, Sweden
基金
瑞典研究理事会;
关键词
polymorphism; linkage; synuclein; mitochondria; toxins; GWAS;
D O I
10.2147/JPRLS.S38954
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Parkinson's disease (PD) is the second most common neurodegenerative disorder, affecting more than 1% of the population over the age of 65 worldwide. Certain rare forms of the disease are monogenetic, and there is increasing evidence that multiple genetic risk factors are also important for common forms of PD. We have summarized the results from candidate gene and genome-wide association findings in sporadic PD as well as linkage and next-generation sequencing studies of familial PD. To date, 19 genetic loci, PARK1-19, have been reported for rare forms of PD, including autosomal-dominant and autosomal-recessive PD. At 14 of these loci, genes have been identified carrying mutations that are linked to affected family members. These genes have also been shown to constitute candidate genes for idiopathic forms of PD, since they may also carry other mutations that merely increase risk. Multiple genetic factors combine in different ways to increase or decrease risk, and several of these risk factors need to be identified in order to begin unraveling the causative pathways leading to the different forms of PD. In this review, we present current and emerging PD candidate genes to help explain the pathways leading to neurodegeneration.
引用
收藏
页码:63 / 75
页数:13
相关论文
共 50 条
  • [1] The genetics of multiple sclerosis: review of current and emerging candidates
    Munoz-Culla, Maider
    Irizar, Haritz
    Otaegui, David
    [J]. APPLICATION OF CLINICAL GENETICS, 2013, 6 : 63 - 73
  • [2] The genetics of neuroendocrine prostate cancers: a review of current and emerging candidates
    Ather, M. Hammad
    Siddiqui, Tahmeena
    [J]. APPLICATION OF CLINICAL GENETICS, 2012, 5 : 105 - 110
  • [3] Current and emerging treatments in Parkinson's disease
    Tan, AKY
    [J]. ANNALS ACADEMY OF MEDICINE SINGAPORE, 2001, 30 (02) : 128 - 133
  • [4] Current and emerging therapeutic targets for Parkinson's disease
    Pingale, Tanvi
    Gupta, Girdhari Lal
    [J]. METABOLIC BRAIN DISEASE, 2021, 36 (01) : 13 - 27
  • [5] Current and emerging therapeutic targets for Parkinson’s disease
    Tanvi Pingale
    Girdhari Lal Gupta
    [J]. Metabolic Brain Disease, 2021, 36 : 13 - 27
  • [6] Current and Emerging MR Methods and Outcome in Rodent Models of Parkinson's Disease: A Review
    Petiet, Alexandra
    [J]. FRONTIERS IN NEUROSCIENCE, 2021, 15
  • [7] Emerging concepts for precision medicine in Parkinson's disease with focus on genetics
    Stute, Lara
    Krueger, Rejko
    [J]. FORTSCHRITTE DER NEUROLOGIE PSYCHIATRIE, 2020, 88 (09) : 558 - 566
  • [8] Emerging Candidate Biomarkers for Parkinson's Disease: a Review
    Saracchi, Enrico
    Fermi, Silvia
    Brighina, Laura
    [J]. AGING AND DISEASE, 2014, 5 (01): : 27 - 34
  • [9] Available and emerging treatments for Parkinson's disease: a review
    Hickey, Patrick
    Stacy, Mark
    [J]. DRUG DESIGN DEVELOPMENT AND THERAPY, 2011, 5 : 241 - 254
  • [10] Current treatment challenges and emerging therapies in Parkinson's disease
    Hauser, RA
    Pahwa, R
    [J]. NEUROLOGIC CLINICS, 2004, 22 (03) : IX - XI